198 related articles for article (PubMed ID: 29374217)
1. Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers.
Kim JH; Han N; Kim MG; Yun HY; Lee S; Bae E; Kim YS; Kim IW; Oh JM
Sci Rep; 2018 Jan; 8(1):1687. PubMed ID: 29374217
[TBL] [Abstract][Full Text] [Related]
2. Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients.
Kim JH; Han N; Kim MG; Kim YW; Jang H; Yun HY; Yu MY; Kim IW; Kim YS; Oh JM
Sci Rep; 2019 Aug; 9(1):11740. PubMed ID: 31409869
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co-treated with tacrolimus: A population analysis.
Yang CL; Sheng CC; Liao GY; Su Y; Feng LJ; Xia Q; Jiao Z; Xu DJ
J Clin Pharm Ther; 2021 Dec; 46(6):1564-1575. PubMed ID: 34312870
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
[TBL] [Abstract][Full Text] [Related]
5. No pharmacokinetic interactions between mycophenolic acid and tacrolimus in renal transplant recipients.
Kagaya H; Miura M; Satoh S; Inoue K; Saito M; Inoue T; Habuchi T; Suzuki T
J Clin Pharm Ther; 2008 Apr; 33(2):193-201. PubMed ID: 18315786
[TBL] [Abstract][Full Text] [Related]
6. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
Musuamba FT; Mourad M; Haufroid V; Demeyer M; Capron A; Delattre IK; Delaruelle F; Wallemacq P; Verbeeck RK
J Clin Pharmacol; 2012 Dec; 52(12):1833-43. PubMed ID: 22207766
[TBL] [Abstract][Full Text] [Related]
7. Single-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial.
Billing H; Höcker B; Fichtner A; van Damme-Lombaerts R; Friman S; Jaray J; Vondrak K; Sarvary E; Dello Strologo L; Oellerich M; von Ahsen N; Tönshoff B
Ther Drug Monit; 2017 Feb; 39(1):21-28. PubMed ID: 28030534
[TBL] [Abstract][Full Text] [Related]
8. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.
Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Fernandes FB; Casarini DE; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2009 Feb; 23(1):137-45. PubMed ID: 19267777
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.
Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455
[TBL] [Abstract][Full Text] [Related]
11. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation.
Filler G; Foster J; Berard R; Mai I; Lepage N
Transplant Proc; 2004 Jun; 36(5):1327-31. PubMed ID: 15251324
[TBL] [Abstract][Full Text] [Related]
12. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.
Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S
Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers.
Guo D; Pang LF; Han Y; Yang H; Wang G; Tan ZR; Zhang W; Zhou HH
Eur J Clin Pharmacol; 2013 Apr; 69(4):843-9. PubMed ID: 23052409
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.
Zhao W; Fakhoury M; Deschênes G; Roussey G; Brochard K; Niaudet P; Tsimaratos M; André JL; Cloarec S; Cochat P; Bensman A; Azougagh S; Jacqz-Aigrain E
J Clin Pharmacol; 2010 Nov; 50(11):1280-91. PubMed ID: 20147615
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
Rong Y; Mayo P; Ensom MHH; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation.
Sobiak J; Resztak M; Głyda M; Szczepaniak P; Chrzanowska M
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):331-8. PubMed ID: 25663618
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
Zhang Q; Tao Y; Zhu Y; Zhu D
Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
[TBL] [Abstract][Full Text] [Related]
20. Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
Kuypers DR; Vanrenterghem Y; Squifflet JP; Mourad M; Abramowicz D; Oellerich M; Armstrong V; Shipkova M; Daems J
Ther Drug Monit; 2003 Oct; 25(5):609-22. PubMed ID: 14508385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
